OpenAI and Anthropic, two of the most prominent artificial intelligence companies, count approximately 90 of the same investors among their backers. The overlap, disclosed in regulatory filings, highlights how deeply intertwined the financial interests behind the two rivals have become.
The investor overlap
Investment firms that hold stakes in both OpenAI and Anthropic include a mix of venture capital funds, asset managers, and corporate venture arms. While neither company released the full list, the figure of roughly 90 common investors emerged from recent filings. That number suggests a significant portion of their funding sources overlap.
Both companies have raised billions of dollars in recent years. OpenAI's valuation has soared past $80 billion, while Anthropic is valued at over $18 billion. The shared investor base means a handful of firms effectively hold sway over both organizations.
When the same institutions bankroll competing startups, questions about independence naturally arise. Investors typically get board seats or advisory roles, giving them insight into both companies' strategies. That could push OpenAI and Anthropic to avoid head-on confrontation in certain markets or product lines.
Sequoia Capital, Andreessen Horowitz, and Thrive Capital are among the big names that have backed both companies. The overlap is especially notable because OpenAI and Anthropic were founded by former colleagues. Anthropic's leadership includes ex-OpenAI researchers who left over disagreements about safety and commercialization.
Having common investors might nudge both toward more cautious product launches or align their approaches to regulation. For regulators, the concentration raises the question of whether the AI sector is becoming too clubby.
Regulatory implications
Antitrust authorities in the U.S. and Europe have already begun scrutinizing investments in AI startups by Big Tech and venture firms. The Federal Trade Commission last year sought information on deals involving AI, including Microsoft's stake in OpenAI. A shared investor pool could attract similar attention.
If a small group of firms holds major stakes in the top AI labs, the risk of coordinated behavior goes up. That doesn't mean collusion, but it could mean softer competition and less aggressive innovation on safety or pricing.
The companies themselves have said they operate independently. But with common investors, the lines blur. The next regulatory filing or enforcement action could test how independent they really are.
